3 min read Health Ark Biopharmaceutical Secures Approval for Aizhida ADHD Treatment Editorial 8 January, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. has received marketing authorization from China’s National Medical Products...Read More
